Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENLIGHTED: Padeliporfin VTP in Low Grade Upper Tract Urothelial Cancer
NCT04620239Phase 3Active, not recruiting
- Sponsor
- Steba Biotech
- Start
- Mar 2021
- Primary completion
- Jul 2026
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 5
01
Overview
A Phase 3 trial of padeliporfin VTP in upper tract urothelial carcinoma (UTUC), sponsored by Steba Biotech. Started Mar 2021; status: active, not recruiting.
02
Drugs
padeliporfin VTP
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT04620239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04620239.